OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
Gabriel Rojas-Jiménez, Daniela Solano, Álvaro Segura, et al.
Frontiers in Medical Technology (2022) Vol. 3
Open Access | Times Cited: 7
Gabriel Rojas-Jiménez, Daniela Solano, Álvaro Segura, et al.
Frontiers in Medical Technology (2022) Vol. 3
Open Access | Times Cited: 7
Showing 7 citing articles:
Passive immunotherapies for COVID‐19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible
Daniele Focosi, Massimo Franchini
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Closed Access | Times Cited: 14
Daniele Focosi, Massimo Franchini
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Closed Access | Times Cited: 14
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1044-1045
Open Access | Times Cited: 12
Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1044-1045
Open Access | Times Cited: 12
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients
Daniele Focosi, Massimo Franchini
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103648-103648
Open Access | Times Cited: 4
Daniele Focosi, Massimo Franchini
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103648-103648
Open Access | Times Cited: 4
Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements
Bruno Deltreggia Benites, Carolina Costa-Lima, Fernanda Batista Rosa Pinto, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 6, pp. 103513-103513
Open Access | Times Cited: 2
Bruno Deltreggia Benites, Carolina Costa-Lima, Fernanda Batista Rosa Pinto, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 6, pp. 103513-103513
Open Access | Times Cited: 2
Development and Characterization of anti-SARS-CoV-2 Intravenous Immunoglobulin from COVID-19 Convalescent Plasma
Mikhail Razumikhin, T. I. Smolyanova, А. М. Николаева, et al.
Immunotherapy (2022) Vol. 14, Iss. 14, pp. 1133-1147
Open Access | Times Cited: 1
Mikhail Razumikhin, T. I. Smolyanova, А. М. Николаева, et al.
Immunotherapy (2022) Vol. 14, Iss. 14, pp. 1133-1147
Open Access | Times Cited: 1
The Importance of Qualitative/Quantitative Analytical Tools in COVID-19 Vaccine Development
Behrouz Seyfinejad, Ommoleila Molavi, Abolghasem Jouyban
ImmunoAnalysis (2023) Vol. 3, pp. 8-8
Open Access
Behrouz Seyfinejad, Ommoleila Molavi, Abolghasem Jouyban
ImmunoAnalysis (2023) Vol. 3, pp. 8-8
Open Access
